Trials / Completed
CompletedNCT04078841
Treating Post-Lyme Disease Syndrome With Acetogenins
Using ReaLife+ to Treat Post-Lyme Disease Syndrome
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Optimal Health Research · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To access the effectiveness of Acetogenins in treating Post-Lyme Disease Syndrome (PLDS).
Detailed description
To access the effectiveness of Acetogenins in treating Post-Lyme Disease Syndrome (PLDS). After failure of antibiotic therapy to relive persistent symptoms of Lyme Disease, the use of Acetogenins to elevate Post-Lyme Disease Syndrome.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | ReaLife+ (RLP) | RLP is a dietary supplement containing Acetogenins, vitamin, mineral and amino acids. |
| OTHER | Inert Brown powder | Brown powder Inert brown powder to look similar to RLP |
Timeline
- Start date
- 2019-07-01
- Primary completion
- 2019-11-14
- Completion
- 2020-01-30
- First posted
- 2019-09-06
- Last updated
- 2020-02-11
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04078841. Inclusion in this directory is not an endorsement.